Virus News and Research

Latest Virus News and Research

Understanding why some people are more vulnerable to COVID-19

What makes the elderly and people with underlying conditions more vulnerable to COVID-19? According to a new study led by McGill University researchers, clues can be found in the proteins involved in initiating infection, as the virus binds to host cells of different animals.

3 Dec 2020

Lessons from Italian neurosurgeons who fought on the frontline of COVID-19 pandemic's first wave

A report by neurosurgeons at the Papa Giovanni XXIII Hospital in Bergamo, Italy, highlights the strategies their unit had to take to help combat the viral illness, which has claimed the lives of more than 1.49 million people worldwide. The study was published in the Journal of Neurosurgery in December 2020.

3 Dec 2020

Can melatonin help prevent severe COVID-19?

A team of researchers at the University of Toronto in Canada has found that melatonin can be an adjuvant to augment the efficacy of anti-SARS-CoV-2 vaccines. They believe that the drug is a potential “silver bullet” to combat the COVID-19 pandemic.

3 Dec 2020

Household composition and ethnicity may contribute to higher COVID-19 mortality: a UK case study

A new study by researchers in the UK found that older people living with relatives are at an increased risk of severe COVID-19 and death. They also revealed that living in a multi-generational household, where extended family members live, was tied to increased COVID-19 mortality.

3 Dec 2020

Come for your eye exam, leave with a band-aid on your arm

With multiple COVID-19 vaccines rapidly heading toward approval, optometrists and dentists are pushing for the authority to immunize patients during routine eye exams and dental cleanings.

3 Dec 2020

As LA County sets new infection record, state leaders’ behavior sends mixed messages

California, like the rest of the nation, is seeing a dramatic rise in COVID infections and deaths — and Los Angeles County has some of the most dire statistics.

3 Dec 2020

High seroprevalence of short-lived anti-SARS-CoV-2 antibodies in Paris

A recent study indicates a high seroprevalence of antibodies against SARS-CoV-2 among individuals working in a Paris-based institute.

3 Dec 2020

NYC hospital workers, knowing how bad it can get, brace for COVID 2nd wave

No single municipality in the country suffered more in the first wave of the pandemic than New York City, which saw more than 24,000 deaths, mainly in the spring. Medical staff in New York know precisely how difficult and dangerous overwhelmed hospitals can be and are braced warily as infections begin to rise again.

3 Dec 2020

Nanoparticles with neutralizing antibodies can inactivate SARS-CoV-2

Using nanoparticles conjugated with SARS-CoV-2 neutralizing antibodies, researchers demonstrated that intense local heating could inactivate the virus.

3 Dec 2020

Long-range allosteric influences on SARS-COV-2-ACE2 stability and detachment

The COVID-19 pandemic is caused by SARS-CoV-2, a novel beta-coronavirus which has numerous spike proteins on its membrane.

3 Dec 2020

N-Glycosylation sites may contribute to spike-mediated invasion by SARS-CoV-2

The sugar residues decorating the spike (S) protein of SARS-CoV-2 are essential to the viral-receptor binding.

3 Dec 2020

Guidelines for accurate amplicon-based sequencing of SARS-CoV-2

A new study describes much-needed guidelines for reliable viral sequencing, validated in a large group of clinical samples.

3 Dec 2020

COVID-19 mutation mapping identifies escape mutations against therapeutic antibodies

A new study maps all known mutations in the SARS-CoV-2 virus, showing how each contributes to escape from individual antibodies.

3 Dec 2020

Scientists develop new bioinformatics pipeline to identify viruses in environmental samples

Researchers from the University of Helsinki have developed a novel bioinformatics pipeline called Lazy pipe for identifying viruses in host-associated or environmental samples.

3 Dec 2020

SARS-CoV-2 enters the CNS via multiple routes and causes various neurological disorders

The COVID-19 pandemic has led to millions of deaths across the globe. The causative agent of this disease is the novel coronavirus, SARS-CoV-2.

3 Dec 2020

Pomegranate extract could inhibit the virus that causes COVID-19

Researchers have conducted a study demonstrating the potential antiviral effects of pomegranate extract against SAR-CoV-2.

3 Dec 2020

The vaginal microbiome may impact the efficacy of HIV prevention therapy

A new study has revealed that vaginal microbial communities are linked with an increased risk of HIV acquisition and may also impact the efficacy of PrEP.

3 Dec 2020

Study: Infants diagnosed with COVID-19 experienced reversible myocardial injury, heart failure

A 2-month-old infant diagnosed with COVID-19 experienced reversible myocardial injury and heart failure, similar to COVID-19 related heart issues seen in adults, according to a case published in JACC: Case Reports.

3 Dec 2020

Scientists report the first map of molecular responses of human lung cells to SARS-CoV-2 infection

In a multi-group collaborative involving the National Emerging Infectious Disease Laboratories (NEIDL), the Center for Regenerative Medicine (CReM), and the Center for Network Systems Biology (CNSB), scientists have reported the first map of the molecular responses of human lung cells to infection by SARS-CoV-2.

2 Dec 2020

Study: Individualized treatment plans can benefit both COVID-19 patients, their caregivers

Returning home after a stay in the hospital and a skilled nursing facility is often overwhelming. New research from Regenstrief Institute and Indiana University shows that individualized treatment plans and instructions would be beneficial to both patients and their caregivers.

2 Dec 2020

Virus News and Research

Latest Virus News and Research

Understanding why some people are more vulnerable to COVID-19

Lessons from Italian neurosurgeons who fought on the frontline of COVID-19 pandemic's first wave

Can melatonin help prevent severe COVID-19?

Household composition and ethnicity may contribute to higher COVID-19 mortality: a UK case study

Come for your eye exam, leave with a band-aid on your arm

As LA County sets new infection record, state leaders’ behavior sends mixed messages

High seroprevalence of short-lived anti-SARS-CoV-2 antibodies in Paris

NYC hospital workers, knowing how bad it can get, brace for COVID 2nd wave

Nanoparticles with neutralizing antibodies can inactivate SARS-CoV-2

Long-range allosteric influences on SARS-COV-2-ACE2 stability and detachment

N-Glycosylation sites may contribute to spike-mediated invasion by SARS-CoV-2

Guidelines for accurate amplicon-based sequencing of SARS-CoV-2

COVID-19 mutation mapping identifies escape mutations against therapeutic antibodies

Scientists develop new bioinformatics pipeline to identify viruses in environmental samples

SARS-CoV-2 enters the CNS via multiple routes and causes various neurological disorders

Pomegranate extract could inhibit the virus that causes COVID-19

The vaginal microbiome may impact the efficacy of HIV prevention therapy

Study: Infants diagnosed with COVID-19 experienced reversible myocardial injury, heart failure

Scientists report the first map of molecular responses of human lung cells to SARS-CoV-2 infection

Study: Individualized treatment plans can benefit both COVID-19 patients, their caregivers

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in